Bacchus-F to please Dong-A

With the possible reclassification of 48 over-the-counter (OTC) drugs as “quasi-drugs,” pharmaceutical companies, many of which saw their sales fall following a government crackdown on kickbacks given to doctors or pharmacies, expect a rebound, but only a few will gain an advantage, analysts claim.

The obvious winner from the reclassification will be Dong-A Pharmaceutical, Korea’s largest dr...